Braun Stacey Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.7M Buy
236,080
+1,201
+0.5% +$141K 0.82% 45
2026
Q2
$23.7M Sell
234,879
-1,163
-0.5% -$120K 0.67% 60
2026
Q1
$22.8M Buy
236,042
+13,549
+6% +$1.39M 0.76% 55
2025
Q4
$23.6M Sell
222,493
-1,180
-0.5% -$137K 0.77% 56
2025
Q3
$28.4M Buy
223,673
+18,967
+9% +$2.26M 0.93% 34
2025
Q2
$25.1M Buy
204,706
+81,501
+66% +$9.31M 0.91% 40
2025
Q1
$12.5M Buy
123,205
+18,298
+17% +$1.79M 0.51% 75
2024
Q4
$9.7M Buy
+104,907
New +$10.3M 0.36% 85

Other funds holding EHC

Braun Stacey Associates's EHC Position: Q3 2026 in Review

Braun Stacey Associates increased its Encompass Health (EHC) stake by 0.51% in Q3 2026, buying an estimated $141K and bringing the position to 236,080 shares worth $28.7M. The position accounts for 0.82% of the portfolio, ranked #45.

Braun Stacey Associates first reported a position in EHC in Q4 2024 and has held it in 8 quarters since. 628 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Braun Stacey Associates held 236,080 shares of Encompass Health worth $28.7M as of Q3 2026.
  • Braun Stacey Associates bought 1,201 Encompass Health shares in Q3 2026, an estimated $141K.
  • Encompass Health made up 0.82% of Braun Stacey Associates's portfolio in Q3 2026, its #45 holding.
  • Braun Stacey Associates first reported a position in Encompass Health in Q4 2024 and has held it in 8 quarters since.
  • 628 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Braun Stacey Associates's 13F filing for Q3 2026, filed 19 Oct 2026.